Why does it matter? Mikah purchased trimipramine ANDA 077361 from Allergan in August 2016 as a part of a huge divestiture for Actavis merger. The price Mikah paid in August 2016 is unknown. Elite paid Mikah $1.2M just 8 months later through an undisclosed Promissory Note. How'd we do? Why wasn't Elite involved in the original deal? Why was a distribution agreement negotiated between Mikah and Dr. Reddy literally a few days before the sale to Elite?
This is an example of how Nasrat does himself and shareholders a disservice by withholding information that could easily overcome the APPEARANCE OF IMPROPRIETY. It is time to demand better from Elite management.
Market Data 
Markets 
AI
